Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free to browse, no account needed Track PMCB with free AI briefings, catalyst countdowns, and dilution alerts.

PMCB · PharmaCyte Biotech, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$17.8M Cash on Hand

49.2mo Cash Runway

Follow PMCB by email Get an email when PMCB pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about PMCB, unsubscribe in one click. Privacy

💰 Cash Runway & Dilution Risk

PMCB holds $17.8M in cash and short-term investments (as of Jul 31, 2026) and burns about $1.1M/quarter from operations, an estimated runway of 49.2 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 20 · Moderate

Cash runway 49 months
Share count +58% in a year +20

Recent financing filings on SEC EDGAR:

Aug 18, 2025 · Private placement (8-K Item 3.02) · 8-K

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when PMCB files for a raise →

Get the full PMCB picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for PMCB and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z